Literature DB >> 17307847

Inactivation of the mismatch repair system in Pseudomonas aeruginosa attenuates virulence but favors persistence of oropharyngeal colonization in cystic fibrosis mice.

Ana Mena1, María D Maciá, Nuria Borrell, Bartolomé Moya, Teresa de Francisco, José L Pérez, Antonio Oliver.   

Abstract

The inactivation of the mismatch repair (MMR) system of Pseudomonas aeruginosa modestly reduced in vitro fitness, attenuated virulence in murine models of acute systemic and respiratory infections, and decreased the initial oropharyngeal colonization potential. In contrast, the inactivation of the MMR system favored long-term persistence of oropharyngeal colonization in cystic fibrosis mice. These results may help in understanding the reasons for the low and high prevalences, respectively, of hypermutable P. aeruginosa strains in acute and chronic infections.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17307847      PMCID: PMC1855878          DOI: 10.1128/JB.00120-07

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  25 in total

1.  Costs and benefits of high mutation rates: adaptive evolution of bacteria in the mouse gut.

Authors:  A Giraud; I Matic; O Tenaillon; A Clara; M Radman; M Fons; F Taddei
Journal:  Science       Date:  2001-03-30       Impact factor: 47.728

2.  Effect of mutS and recD mutations on Salmonella virulence.

Authors:  T C Zahrt; N Buchmeier; S Maloy
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

3.  A hypermutator phenotype attenuates the virulence of Listeria monocytogenes in a mouse model.

Authors:  Delphine Mérino; Hélène Réglier-Poupet; Patrick Berche; Alain Charbit
Journal:  Mol Microbiol       Date:  2002-05       Impact factor: 3.501

4.  Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen.

Authors:  C K Stover; X Q Pham; A L Erwin; S D Mizoguchi; P Warrener; M J Hickey; F S Brinkman; W O Hufnagle; D J Kowalik; M Lagrou; R L Garber; L Goltry; E Tolentino; S Westbrock-Wadman; Y Yuan; L L Brody; S N Coulter; K R Folger; A Kas; K Larbig; R Lim; K Smith; D Spencer; G K Wong; Z Wu; I T Paulsen; J Reizer; M H Saier; R E Hancock; S Lory; M V Olson
Journal:  Nature       Date:  2000-08-31       Impact factor: 49.962

5.  Mutator natural Escherichia coli isolates have an unusual virulence phenotype.

Authors:  B Picard; P Duriez; S Gouriou; I Matic; E Denamur; F Taddei
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

6.  The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants.

Authors:  Antonio Oliver; Fernando Baquero; Jesús Blázquez
Journal:  Mol Microbiol       Date:  2002-03       Impact factor: 3.501

7.  Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis.

Authors:  Michael Hogardt; Christina Hoboth; Sabine Schmoldt; Christine Henke; Lutz Bader; Jürgen Heesemann
Journal:  J Infect Dis       Date:  2006-11-22       Impact factor: 5.226

8.  Lack of association between hypermutation and antibiotic resistance development in Pseudomonas aeruginosa isolates from intensive care unit patients.

Authors:  Olivia Gutiérrez; Carlos Juan; José L Pérez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

9.  Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection.

Authors:  Fadie T Coleman; Simone Mueschenborn; Gloria Meluleni; Christopher Ray; Vincent J Carey; Sara O Vargas; Carolyn L Cannon; Frederick M Ausubel; Gerald B Pier
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-10       Impact factor: 11.205

Review 10.  Pathophysiology and management of pulmonary infections in cystic fibrosis.

Authors:  Ronald L Gibson; Jane L Burns; Bonnie W Ramsey
Journal:  Am J Respir Crit Care Med       Date:  2003-10-15       Impact factor: 21.405

View more
  21 in total

1.  Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates.

Authors:  Gabriel Cabot; Laura Zamorano; Bartolomé Moyà; Carlos Juan; Alfonso Navas; Jesús Blázquez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2016-01-04       Impact factor: 5.191

2.  Increased susceptibility to colistin in hypermutable Pseudomonas aeruginosa strains from chronic respiratory infections.

Authors:  M D Maciá; A Mena; N Borrell; J L Pérez; A Oliver
Journal:  Antimicrob Agents Chemother       Date:  2007-09-24       Impact factor: 5.191

3.  Playing fast and loose with mutation.

Authors:  Alison E Mather; Simon R Harris
Journal:  Nat Rev Microbiol       Date:  2013-12       Impact factor: 60.633

4.  Chronic Airway Colonization by Achromobacter xylosoxidans in Cystic Fibrosis Patients Is Not Sustained by Their Domestic Environment.

Authors:  Chloé Dupont; Estelle Jumas-Bilak; Clara Doisy; Fabien Aujoulat; Raphaël Chiron; Hélène Marchandin
Journal:  Appl Environ Microbiol       Date:  2018-11-15       Impact factor: 4.792

Review 5.  Hypermutation and stress adaptation in bacteria.

Authors:  R Jayaraman
Journal:  J Genet       Date:  2011-08       Impact factor: 1.166

Review 6.  Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?

Authors:  Alejandro Beceiro; María Tomás; Germán Bou
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

7.  Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.

Authors:  Xavier Mulet; María D Maciá; Ana Mena; Carlos Juan; José L Pérez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

8.  Analysis of acquisition of Pseudomonas aeruginosa gastrointestinal mucosal colonization and horizontal transmission in a murine model.

Authors:  Akinobu Kamei; Andrew Y Koh; Mihaela Gadjeva; Gregory P Priebe; Stephen Lory; Gerald B Pier
Journal:  J Infect Dis       Date:  2010-01-01       Impact factor: 5.226

9.  Sublethal ciprofloxacin treatment leads to rapid development of high-level ciprofloxacin resistance during long-term experimental evolution of Pseudomonas aeruginosa.

Authors:  Karin Meinike Jørgensen; Tina Wassermann; Peter Østrup Jensen; Wang Hengzuang; Søren Molin; Niels Høiby; Oana Ciofu
Journal:  Antimicrob Agents Chemother       Date:  2013-06-17       Impact factor: 5.191

10.  Pseudomonas aeruginosa RsmA plays an important role during murine infection by influencing colonization, virulence, persistence, and pulmonary inflammation.

Authors:  Heidi Mulcahy; Julie O'Callaghan; Eoin P O'Grady; María D Maciá; Nuria Borrell; Cristina Gómez; Pat G Casey; Colin Hill; Claire Adams; Cormac G M Gahan; Antonio Oliver; Fergal O'Gara
Journal:  Infect Immun       Date:  2007-11-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.